glp 1 obesity treatment The Benefits of GLP-1 Therapy: Beyond Weight Loss GLP-1 Agonists For Obesity In

Description

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been pivotal for obesity treatment, achieving 1525 % weight loss over 1224 months, but questions remain about the potential influence of concomitant losses in muscle mass

Despite the benefits of weight reduction, there are many challenges in losing weight and maintaining long-term weight loss

The ADA now recommends GLP1 RAs with proven benefit to slow CKD progression and reduce CV risk in people with type 2 diabetes

Fernando lvarez Guisasola y Xavier Cos Claramunt

Altimmune just made a big move in the world of GLP-1 research, but this time, its not about obesity.The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD